Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) announces its participation at the MEDICA 2022 trade fair in Düsseldorf, Germany, from November 15-17. This renowned event, the largest medical trade fair globally, attracts thousands of exhibitors from over 50 countries. Co-Dx aims to showcase its in vitro diagnostic products for COVID-19 and other infectious diseases, alongside its innovative CoPrimer™ technology. Attendees are encouraged to visit Booth 3D15 for more insights on the Company’s offerings, including the upcoming Co-Dx PCR Home platform.

SALT LAKE CITY, Nov. 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth this week at the MEDICA 2022 trade fair in Düsseldorf, Germany from 15-17 November.

After more than 40 years, MEDICA has become the largest medical trade fair in the world, attracting thousands of exhibitors from more than 50 countries. The Company expects to use the opportunity to generate increased interest in its suite of in vitro diagnostic and research products for COVID-19 and other infectious diseases, and to introduce and promote its CoPrimer™ technology and applications to a wide audience of international attendees.

Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR Home platform, are invited to visit Booth 3D15.

To learn more about the fair, including in-person and virtual registration details, please visit https://www.medica-tradefair.com.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medica-2022-trade-fair-in-dusseldorf-germany-301676752.html

SOURCE Co-Diagnostics

FAQ

What event is Co-Diagnostics, Inc. attending in November 2022?

Co-Diagnostics, Inc. is attending the MEDICA 2022 trade fair in Düsseldorf, Germany from November 15-17.

What is the significance of the MEDICA trade fair?

MEDICA is the largest medical trade fair in the world, hosting thousands of exhibitors from over 50 countries.

Where can I find Co-Diagnostics at MEDICA 2022?

Co-Diagnostics will be at Booth 3D15 during the MEDICA 2022 trade fair.

What technology will Co-Diagnostics showcase at the MEDICA trade fair?

Co-Diagnostics will promote its CoPrimer™ technology and its suite of diagnostic products for COVID-19.

What products does Co-Diagnostics focus on?

Co-Diagnostics specializes in in vitro diagnostic products for COVID-19 and other infectious diseases.